Stocks and securities in focus
Security | Change (%) | 1w ▼ | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Arbutus Biopharma Corp. | 0.790% | 17.171% | 24.334% | 108.740% | 78.998% | 44.242% | 152.645% |
Insulet Corp. | -2.030% | 5.643% | 5.730% | 20.566% | -2.368% | -24.346% | 36.041% |
Rockwell Medical Inc. | -0.220% | 3.525% | 69.617% | 41.023% | 55.825% | -53.697% | -89.960% |
aTyr Pharma Inc | 5.520% | 2.994% | 8.176% | 14.667% | 33.333% | -61.947% | -37.226% |
Abeona Therapeutics Inc. | -2.570% | 1.215% | 21.951% | 32.205% | 6.157% | -81.007% | -93.025% |
UnitedHealth Group Inc. | -0.090% | 0.937% | 3.855% | 19.867% | 13.075% | 53.286% | 159.350% |
Ligand Pharmaceuticals | 0.540% | -0.543% | 1.667% | 53.782% | 40.769% | -20.779% | 12.091% |
Exelixis Inc. | -1.510% | -0.775% | -7.393% | 11.514% | 5.347% | 36.917% | 31.925% |
Catalyst Pharmaceutical Partners Inc | 0.250% | -1.829% | 7.279% | 51.092% | 15.701% | 319.505% | 199.667% |
Kala Pharmaceuticals Inc. | -0.870% | -1.914% | -4.026% | -52.013% | -21.396% | -96.225% | - |
UCB S.A. | 0.440% | -2.495% | 2.168% | 94.242% | 103.518% | 69.649% | 134.971% |
Immutep LTD ADR | -2.560% | -2.521% | 33.333% | 29.609% | 6.422% | -34.463% | 73.601% |
Ultragenyx Pharmaceutical Inc. | -1.780% | -2.745% | 11.211% | 29.167% | 14.286% | -41.988% | 20.097% |
Corvus Pharmaceuticals Inc | -2.080% | -4.206% | 19.661% | 143.448% | 132.237% | 54.825% | 6.937% |
Intuitive Surgical Inc | 0.950% | -4.446% | 0.141% | 52.691% | 39.160% | 39.403% | 178.562% |
Exact Sciences | 0.160% | -4.550% | 1.524% | -27.213% | -22.253% | -39.150% | -51.396% |
Regenxbio Inc | 1.980% | -4.630% | -6.364% | -36.420% | -38.323% | -63.423% | -65.390% |
Carbylan Therapeutics Inc | -2.650% | -5.172% | -1.786% | 8.911% | 0.917% | -34.911% | -19.118% |
United Therapeutics | -0.030% | -5.228% | 2.870% | 48.264% | 57.276% | 77.159% | 328.062% |
Halozyme Therapeutics Inc. | -2.760% | -7.618% | 6.998% | 48.263% | 57.637% | 49.930% | 269.427% |
AC Immune Ltd | -2.680% | -8.007% | -14.422% | -11.620% | -38.356% | -55.335% | -43.703% |
SELLAS Life Sciences Group Inc | -6.160% | -8.076% | -3.080% | -27.995% | 9.744% | -86.481% | -82.948% |
Cardiff Oncology Inc. | 3.220% | -8.489% | -2.454% | 13.033% | 44.985% | -69.472% | 11.072% |
Syros Pharmaceuticals Inc. | 2.190% | -9.272% | -70.851% | -62.050% | -79.242% | -96.914% | - |
Caredx Inc | -0.980% | -10.213% | -2.357% | 171.556% | 110.690% | -59.603% | - |
WAVE Life Sciences Ltd | -2.130% | -10.769% | -15.636% | 14.286% | 1.310% | -6.995% | - |
Viking Therapeutics Inc | 1.020% | -15.822% | -4.348% | 228.668% | 179.325% | 774.329% | 656.857% |